ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,778Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 625

$857K Total Retail Price of All Prescriptions

Rank: 48 out of 625

607 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 12,407 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 618 443 S3 1 4
OMEPRAZOLE 442 383 2 6
SIMVASTATIN 415 355 3 2
LISINOPRIL 411 303 4 5
LEVOTHYROXINE SODIUM 375 332 5 3
FUROSEMIDE 352 304 6 7
ZOLPIDEM TARTRATE 350 287 7 13
METOPROLOL TARTRATE 339 274 8 11
AMLODIPINE BESYLATE 327 295 9 1
HYDROCHLOROTHIAZIDE 311 272 10 12
GABAPENTIN 279 237 11 14
PRAVASTATIN SODIUM 274 223 12 8
POTASSIUM CHLORIDE 240 239 13 19
METOPROLOL SUCCINATE 233 217 14 15
TRAMADOL HCL 223 199 15 16
WARFARIN SODIUM 214 174 16 20
METFORMIN HCL 196 123 17 10
ATORVASTATIN CALCIUM 196 193 17 9
SERTRALINE HCL 180 145 19 26
ALLOPURINOL 159 110 20 29
CARVEDILOL 154 135 21 23
NEXIUM 151 117 22 21
LOSARTAN POTASSIUM 143 121 23 18
TAMSULOSIN HCL 135 123 24 36
DIGOXIN 127 115 25 55
CLOPIDOGREL 116 105 26 30
FENTANYL 116 79 S2 26 110
MELOXICAM 115 95 28 31
CITALOPRAM HBR 115 102 28 24
RANITIDINE HCL 114 95 30 25
CELEBREX 110 91 31 72
PREDNISONE 108 89 32 37
PANTOPRAZOLE SODIUM 104 84 33 44
FENOFIBRATE 103 74 34 59
FLUTICASONE PROPIONATE 103 87 34 32
ISOSORBIDE MONONITRATE ER 102 102 36 49
LANTUS SOLOSTAR 95 61 37 85
TRAZODONE HCL 91 54 38 51
FLUOXETINE HCL 90 36 39 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 79 39 27
AMLODIPINE BESYLATE-BENAZEPRIL 88 75 41 48
ALENDRONATE SODIUM 85 85 42 34
DOXYCYCLINE HYCLATE 85 69 42 141
INSULIN SYRINGE 84 51 44 77
NAMENDA 81 81 45 45
KLOR-CON 10 81 79 45 134
MECLIZINE HCL 80 79 47 113
DONEPEZIL HCL 79 70 48 33
LOSARTAN-HYDROCHLOROTHIAZIDE 78 64 49 38
FAMOTIDINE 74 62 50 73
AMITRIPTYLINE HCL 74 71 R 50 61
BENAZEPRIL HCL 73 63 52 35
PEN NEEDLE 72 57 53 100
METHYLPREDNISOLONE 71 61 54 120
CYMBALTA 70 60 55 46
ATENOLOL 68 68 56 22
ZETIA 68 64 56 66
OXYCODONE HCL 67 40 S2 58 79
PROAIR HFA 67 47 58 57
ROPINIROLE HCL 65 44 60 96
CYCLOBENZAPRINE HCL 64 31 R 61 65
ESCITALOPRAM OXALATE 64 64 61 67
PLAVIX 64 61 61 43
SYMBICORT 61 48 64 123
ADVAIR DISKUS 60 50 65 63
DIOVAN 60 47 65 28
LANTUS 59 54 67 54
MIRTAZAPINE 59 54 67 69
PROMETHAZINE HCL 58 28 R 69 84
CIPROFLOXACIN HCL 57 54 70 60
METOCLOPRAMIDE HCL 56 54 71 133
NITROSTAT 56 54 71 202
ESTRADIOL 56 48 R 71 128
TRIAMCINOLONE ACETONIDE 55 47 74 168
AZITHROMYCIN 54 46 75 40
NOVOLOG 52 43 76 112
ENALAPRIL MALEATE 51 39 77 81
DILTIAZEM 24HR CD 51 48 77 131
FINASTERIDE 50 50 79 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.